Sequana Medical NV, an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, announces that its management team will participate in two upcoming virtual investor conferences, being held in parallel with the JP Morgan 39th Annual Healthcare Conference.
December 17, 2020
· 4 min read